Skip to main content
Top
Published in: Journal of Clinical Immunology 4/2012

01-08-2012

Cross-Reactive Antibodies to Target Proteins are Dependent upon Oligomannose Glycosylated Epitopes in HTLV-1 Associated Neurological Disease

Authors: Sangmin Lee, Yoojin Shin, Daniel Clark, Eduardo Gotuzzo, Michael C. Levin

Published in: Journal of Clinical Immunology | Issue 4/2012

Login to get access

Abstract

Our lab recently identified a cross-reactive antibody response between human T-lymphotropic virus type-1-p24-(gag) (HTLV-1-p24-(gag)) and peroxiredoxin-1 (PrX-1) as potentially contributing to the pathogenesis of HTLV-1 associated neurological disease via molecular mimicry. These targets proteins were glycosylated, yet the glycan side chains immunoreactive with the immunoglobulins were unknown. Using a combination of lectin isolation and serial enzymatic deglycosylation of glycoproteins, we determined that the immunoreactive epitopes contained branched oligomannose side chains. These data suggest that post-translational glycosylation specifically related to oligomannose immunoreactivity to both the infecting and host antigens may contribute to molecular mimicry and be important in the pathogenesis of HTLV-1 associated neurological disease.
Literature
1.
go back to reference Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science. 2001;291:2370–6.PubMedCrossRef Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science. 2001;291:2370–6.PubMedCrossRef
2.
go back to reference Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 2007;446:1023–9.PubMedCrossRef Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 2007;446:1023–9.PubMedCrossRef
3.
go back to reference Rachmilewitz J. Glycosylation: An intrinsic sign of “danger”. Self Nonself. 2010;1:250–4.PubMed Rachmilewitz J. Glycosylation: An intrinsic sign of “danger”. Self Nonself. 2010;1:250–4.PubMed
4.
5.
go back to reference Green RS, Stone EL, Tenno M, Lehtonen E, Farquhar MG, Marth JD. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. Immunity. 2007;27:308–20.PubMedCrossRef Green RS, Stone EL, Tenno M, Lehtonen E, Farquhar MG, Marth JD. Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. Immunity. 2007;27:308–20.PubMedCrossRef
6.
go back to reference Lee S, Shin Y, Marler J, Levin MC. Post-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological disease. J Neuroimmunol. 2008;204:140–8.PubMedCrossRef Lee S, Shin Y, Marler J, Levin MC. Post-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological disease. J Neuroimmunol. 2008;204:140–8.PubMedCrossRef
7.
go back to reference Lee S, Levin MC. Molecular mimicry in neurological disease: what is the evidence? Cell Mol Life Sci. 2008;65:1161–75.PubMedCrossRef Lee S, Levin MC. Molecular mimicry in neurological disease: what is the evidence? Cell Mol Life Sci. 2008;65:1161–75.PubMedCrossRef
8.
go back to reference Levin MC, Lee SM, Kalume F, Morcos Y, Dohan Jr FC, Hasty KA, Callaway JC, Zunt J, Desiderio D, Stuart JM. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med. 2002;8:509–13.PubMedCrossRef Levin MC, Lee SM, Kalume F, Morcos Y, Dohan Jr FC, Hasty KA, Callaway JC, Zunt J, Desiderio D, Stuart JM. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med. 2002;8:509–13.PubMedCrossRef
9.
go back to reference Lee SM, Morocos Y, Jang H, Stuart JM, Levin MC. HTLV-1 induced molecular mimicry in neurologic disease. In: Oldstone M, editor. Molecular Mimicry: Infection Inducing Autoimmune Disease. New York: Springer; 2005. Lee SM, Morocos Y, Jang H, Stuart JM, Levin MC. HTLV-1 induced molecular mimicry in neurologic disease. In: Oldstone M, editor. Molecular Mimicry: Infection Inducing Autoimmune Disease. New York: Springer; 2005.
10.
11.
go back to reference Kirvan CA, Cox CJ, Swedo SE, Cunningham MW. Tubulin is a neuronal target of autoantibodies in Sydenham’s chorea. J Immunol. 2007;178:7412–21.PubMed Kirvan CA, Cox CJ, Swedo SE, Cunningham MW. Tubulin is a neuronal target of autoantibodies in Sydenham’s chorea. J Immunol. 2007;178:7412–21.PubMed
12.
go back to reference Wucherpfennig K, Strominger J. Molecular Mimicry in T Cell-Mediated Autoimmunity: Viral Peptides Activate Human T Cell Clones Specific for Myelin Basic Protein. Cell. 1995;80:695–705.PubMedCrossRef Wucherpfennig K, Strominger J. Molecular Mimicry in T Cell-Mediated Autoimmunity: Viral Peptides Activate Human T Cell Clones Specific for Myelin Basic Protein. Cell. 1995;80:695–705.PubMedCrossRef
13.
go back to reference Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol. 2002;3:940–3.PubMedCrossRef Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol. 2002;3:940–3.PubMedCrossRef
14.
go back to reference Rice JS, Kowal C, Volpe BT, DeGiorgio LA, Diamond B. Molecular mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-antigens. Curr Top Microbiol Immunol. 2005;296:137–51.PubMedCrossRef Rice JS, Kowal C, Volpe BT, DeGiorgio LA, Diamond B. Molecular mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-antigens. Curr Top Microbiol Immunol. 2005;296:137–51.PubMedCrossRef
15.
go back to reference Oldstone MB. A suspenseful game of ‘hide and seek’ between virus and host. Nat Immunol. 2007;8:325–7.PubMedCrossRef Oldstone MB. A suspenseful game of ‘hide and seek’ between virus and host. Nat Immunol. 2007;8:325–7.PubMedCrossRef
16.
go back to reference Oldstone M. Molecular mimicry and immune mediated disease. FASEB J. 1998;12:1255–65.PubMed Oldstone M. Molecular mimicry and immune mediated disease. FASEB J. 1998;12:1255–65.PubMed
17.
go back to reference Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985;230:1043–5.PubMedCrossRef Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985;230:1043–5.PubMedCrossRef
18.
go back to reference Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914–20.PubMedCrossRef Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914–20.PubMedCrossRef
19.
go back to reference Levin M, Lehky T, Flerlage N, Katz D, Kingma D, Jaffe E, Heiss J, Patronas N, McFarland H, Jacobson S. Immunopathogenesis of HTLV-1 associated neurologic disease based on a spinal cord biopsy from a patient with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). New Eng J Med. 1997;336:839–45.PubMedCrossRef Levin M, Lehky T, Flerlage N, Katz D, Kingma D, Jaffe E, Heiss J, Patronas N, McFarland H, Jacobson S. Immunopathogenesis of HTLV-1 associated neurologic disease based on a spinal cord biopsy from a patient with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). New Eng J Med. 1997;336:839–45.PubMedCrossRef
20.
go back to reference Levin MC, Jacobson S. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol. 1997;3:126–40.PubMedCrossRef Levin MC, Jacobson S. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol. 1997;3:126–40.PubMedCrossRef
21.
go back to reference Poeisz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R. Detection and isolation of type Cretrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci. 1980;77:7415–9.CrossRef Poeisz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo R. Detection and isolation of type Cretrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci. 1980;77:7415–9.CrossRef
22.
go back to reference Gessain A, Vernant J, Maurs L, Barin F, Gout O, Calender A. The, G.d. Antibodies to human T-lymphotropic virus I in patients with tropical spastic paraparesis. Lancet. 1985;2:407–10.PubMedCrossRef Gessain A, Vernant J, Maurs L, Barin F, Gout O, Calender A. The, G.d. Antibodies to human T-lymphotropic virus I in patients with tropical spastic paraparesis. Lancet. 1985;2:407–10.PubMedCrossRef
23.
go back to reference Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031–2.PubMedCrossRef Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031–2.PubMedCrossRef
24.
go back to reference Levin MC, Lee SM, Morcos Y, Brady J, Stuart J. Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. J Infect Dis. 2002;186:1514–7.PubMedCrossRef Levin MC, Lee SM, Morcos Y, Brady J, Stuart J. Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. J Infect Dis. 2002;186:1514–7.PubMedCrossRef
25.
go back to reference Lee SM, Dunnavant FD, Jang H, Zunt J, Levin MC. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease. Neurosci Lett. 2006;401:188–93.PubMedCrossRef Lee SM, Dunnavant FD, Jang H, Zunt J, Levin MC. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease. Neurosci Lett. 2006;401:188–93.PubMedCrossRef
26.
go back to reference Kalume F, Lee SM, Morcos Y, Callaway JC, Levin MC. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing. J Neurosci Res. 2004;77:82–9.PubMedCrossRef Kalume F, Lee SM, Morcos Y, Callaway JC, Levin MC. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing. J Neurosci Res. 2004;77:82–9.PubMedCrossRef
27.
go back to reference Lee S, Xu L, Shin Y, Gardner L, Hartzes A, Dohan FC, Raine C, Homayouni R, Levin MC. A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease. J Neuroimmunol. 2011;235:56–69.PubMedCrossRef Lee S, Xu L, Shin Y, Gardner L, Hartzes A, Dohan FC, Raine C, Homayouni R, Levin MC. A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease. J Neuroimmunol. 2011;235:56–69.PubMedCrossRef
28.
go back to reference De Castro-Costa CM, Araujo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, de Paula SM, Ishak R, Ribas JG, Rovirosa LC, et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses. 2006;22:931–5.PubMedCrossRef De Castro-Costa CM, Araujo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, de Paula SM, Ishak R, Ribas JG, Rovirosa LC, et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses. 2006;22:931–5.PubMedCrossRef
29.
go back to reference Levin M, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chen G, Posner J, Jacobson S. Neuronal molecular mimicry in immune mediated neurologic disease. Ann Neurol. 1998;44:87–98.PubMedCrossRef Levin M, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chen G, Posner J, Jacobson S. Neuronal molecular mimicry in immune mediated neurologic disease. Ann Neurol. 1998;44:87–98.PubMedCrossRef
30.
go back to reference Cummings RD, Etzler ME. Antibodies and Lectins in Glycan Analysis. In. 2009. Cummings RD, Etzler ME. Antibodies and Lectins in Glycan Analysis. In. 2009.
31.
go back to reference Lal R. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-1 and HTLV-II. J Acq Imm Def Syn and Human Retro. 1996;13:S170–8.CrossRef Lal R. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-1 and HTLV-II. J Acq Imm Def Syn and Human Retro. 1996;13:S170–8.CrossRef
32.
go back to reference Soldan SS, Graf MD, Waziri A, Flerlage AN, Robinson SM, Kawanishi T, Leist TP, Lehky TJ, Levin MC, Jacobson S. HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease. J Infect Dis. 1999;180:685–94.PubMedCrossRef Soldan SS, Graf MD, Waziri A, Flerlage AN, Robinson SM, Kawanishi T, Leist TP, Lehky TJ, Levin MC, Jacobson S. HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease. J Infect Dis. 1999;180:685–94.PubMedCrossRef
33.
go back to reference Le Blanc I, Blot V, Bouchaert I, Salamero J, Goud B, Rosenberg AR, Dokhelar MC. Intracellular distribution of human T-cell leukemia virus type 1 Gag proteins is independent of interaction with intracellular membranes. J Virol. 2002;76:905–11.PubMedCrossRef Le Blanc I, Blot V, Bouchaert I, Salamero J, Goud B, Rosenberg AR, Dokhelar MC. Intracellular distribution of human T-cell leukemia virus type 1 Gag proteins is independent of interaction with intracellular membranes. J Virol. 2002;76:905–11.PubMedCrossRef
34.
go back to reference Delamarre L, Rosenberg AR, Pique C, Pham D, Callebaut I, Dokhelar MC. The HTLV-I envelope glycoproteins: structure and functions. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S85–91.PubMedCrossRef Delamarre L, Rosenberg AR, Pique C, Pham D, Callebaut I, Dokhelar MC. The HTLV-I envelope glycoproteins: structure and functions. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S85–91.PubMedCrossRef
36.
go back to reference Osame M. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J Neurovirol. 2002;8:359–64.PubMedCrossRef Osame M. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J Neurovirol. 2002;8:359–64.PubMedCrossRef
37.
go back to reference Plummer Jr TH, Tarentino AL. Purification of the oligosaccharide-cleaving enzymes of Flavobacterium meningosepticum. Glycobiology. 1991;1:257–63.PubMedCrossRef Plummer Jr TH, Tarentino AL. Purification of the oligosaccharide-cleaving enzymes of Flavobacterium meningosepticum. Glycobiology. 1991;1:257–63.PubMedCrossRef
38.
go back to reference Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology. 2002;12:43R–56.PubMedCrossRef Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology. 2002;12:43R–56.PubMedCrossRef
39.
go back to reference Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446:1017–22.PubMedCrossRef Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446:1017–22.PubMedCrossRef
40.
go back to reference Hart GW, West CM. Nucleocytoplasmic Glycosylation. In. 2009. Hart GW, West CM. Nucleocytoplasmic Glycosylation. In. 2009.
41.
go back to reference Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7:255–66.PubMedCrossRef Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7:255–66.PubMedCrossRef
42.
43.
go back to reference Jernigan M, Morcos Y, Lee SM, Dohan Jr FC, Raine C, Levin MC. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology. 2003;60:1320–7.PubMedCrossRef Jernigan M, Morcos Y, Lee SM, Dohan Jr FC, Raine C, Levin MC. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology. 2003;60:1320–7.PubMedCrossRef
44.
go back to reference Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990;348:245–8.PubMedCrossRef Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990;348:245–8.PubMedCrossRef
45.
go back to reference Lal RB, Giam C-Z, Coligan JE, Rudolph DL. Differential Immune Responsiveness to the Immunodominant Epitopes of Regulatory Proteins (tax and rex) in Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy. J Infect Dis. 1994;169:496–503.PubMedCrossRef Lal RB, Giam C-Z, Coligan JE, Rudolph DL. Differential Immune Responsiveness to the Immunodominant Epitopes of Regulatory Proteins (tax and rex) in Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy. J Infect Dis. 1994;169:496–503.PubMedCrossRef
46.
go back to reference Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP, Bangham CR. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood. 2002;99:3335–41.PubMedCrossRef Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP, Bangham CR. High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood. 2002;99:3335–41.PubMedCrossRef
47.
go back to reference Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A. 1999;96:3848–53.PubMedCrossRef Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A. 1999;96:3848–53.PubMedCrossRef
48.
go back to reference Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, et al. Analysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4:586–93.PubMedCrossRef Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, et al. Analysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4:586–93.PubMedCrossRef
49.
go back to reference DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001;7:1189–93.PubMedCrossRef DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001;7:1189–93.PubMedCrossRef
50.
go back to reference Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B, Straus S, et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nature Medicine. 1999;5:1375–82.PubMedCrossRef Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B, Straus S, et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nature Medicine. 1999;5:1375–82.PubMedCrossRef
51.
go back to reference Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A. 2004;101:11404–9.PubMedCrossRef Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A. 2004;101:11404–9.PubMedCrossRef
52.
go back to reference Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis. 2001;1:29–37.PubMedCrossRef Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis. 2001;1:29–37.PubMedCrossRef
53.
go back to reference Nuti F, Peroni E, Real-Fernandez F, Bonache MA, Le Chevalier-Isaad A, Chelli M, Lubin-Germain N, Uziel J, Rovero P, Lolli F, et al. Posttranslationally modified peptides efficiently mimicking neoantigens: a challenge for theragnostics of autoimmune diseases. Biopolymers. 2010;94:791–9.PubMedCrossRef Nuti F, Peroni E, Real-Fernandez F, Bonache MA, Le Chevalier-Isaad A, Chelli M, Lubin-Germain N, Uziel J, Rovero P, Lolli F, et al. Posttranslationally modified peptides efficiently mimicking neoantigens: a challenge for theragnostics of autoimmune diseases. Biopolymers. 2010;94:791–9.PubMedCrossRef
54.
go back to reference Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A. 2005;102:13992–7.PubMedCrossRef Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A. 2005;102:13992–7.PubMedCrossRef
Metadata
Title
Cross-Reactive Antibodies to Target Proteins are Dependent upon Oligomannose Glycosylated Epitopes in HTLV-1 Associated Neurological Disease
Authors
Sangmin Lee
Yoojin Shin
Daniel Clark
Eduardo Gotuzzo
Michael C. Levin
Publication date
01-08-2012
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2012
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-012-9652-9

Other articles of this Issue 4/2012

Journal of Clinical Immunology 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.